Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste.Most ...

Chicago, IL – January 15, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...

Embracing a pluralistic vision of corporate governance will help us ensure capitalism's legitimacy and sustainability.

And while Wood said the pharma still isn’t interested in joining the overcrowded obesity landscape, GSK is considering ways ...

GSK plans five new product approvals by 2025, highlights strong specialty growth, and acquires IDRx for $1 billion to expand its oncology portfolio.

GSK PLC GSK shares rallied 2.63% to £13.28 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 1.21% to 8,301.13. Supported by ...

Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.

Yesterday, spots of pink could be spotted on the streets of San Francisco, and it wasn’t a coincidence. Members of the ...

Most treatments being pursued today to protect against Alzheimer’s disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and ...

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...